Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer

Eitemau Tebyg

• Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy
  gan: Lazzari, Chiara, et al.
  Cyhoeddwyd: (2019)
• Temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer
  gan: Lazzari, Chiara, et al.
  Cyhoeddwyd: (2018)
• Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer
  gan: Gregorc, Vanesa, et al.
  Cyhoeddwyd: (2018)
• Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
  gan: Lazzari, Chiara, et al.
  Cyhoeddwyd: (2018)
• History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature
  gan: Lazzari, Chiara, et al.
  Cyhoeddwyd: (2021)